Lincoln Pharmaceuticals Ltd. - Research Center
531633 LINCOLN Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 291.61 | 264.08 | 222.42 | 245.38 | 223.32 |
| Operating profit | 51.86 | 45.82 | 40.89 | 52.17 | 48.24 |
| Interest | 0.81 | 0.55 | 0.87 | 0.58 | 0.54 |
| Gross profit | 67.44 | 57.45 | 44.54 | 57.68 | 50.89 |
| EPS (Rs) | 23.30 | 19.33 | 14.29 | 20.13 | 17.59 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 16.39 | 12.18 | 4.53 | 6.09 | 3.19 |
| Stock adjustment | 9.91 | -4.31 | -11.67 | -1.84 | 6.18 |
| Raw material | 92.36 | 95.29 | 83.67 | 60.07 | 47.49 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 51.41 | 45.98 | 34.35 | 30.21 | 24.72 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 86.06 | 81.30 | 75.19 | 104.77 | 96.70 |
| Provisions made | - | - | - | - | - |
| Depreciation | 5.13 | 4.49 | 4.18 | 2.95 | 2.83 |
| Taxation | 15.65 | 14.23 | 11.74 | 14.47 | 12.88 |
| Net profit / loss | 46.67 | 38.72 | 28.63 | 40.26 | 35.19 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 20.03 | 20.03 | 20.03 | 20.00 | 20.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 17.79 | 17.35 | 18.38 | 21.26 | 21.60 |
| GPM (%) | 21.90 | 20.80 | 19.63 | 22.94 | 22.47 |
| NPM (%) | 15.15 | 14.02 | 12.61 | 16.01 | 15.53 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis